Priscilla V. Daniel

Kattankulathur, TN, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Molecular insights of a Unani formulation in targeting fibrosis-associated diseases.

Molecular insights of a Unani formulation in targeting fibrosis-associated diseases.

Journal: Frontiers in pharmacology
Published: February 23, 2026

Letter to the editor: Molecular stratification in papillary thyroid carcinoma: Should RET fusions redefine aggressiveness in the post-BRAF era?

Letter to the editor: Molecular stratification in papillary thyroid carcinoma: Should RET fusions redefine aggressiveness in the post-BRAF era?

Journal: Oral oncology
Published: July 19, 2025

Letter to the editor: Risk-adapted chemotherapy in NPC: Aligning EBV DNA dynamics with AJCC staging for individualized treatment.

Letter to the editor: Risk-adapted chemotherapy in NPC: Aligning EBV DNA dynamics with AJCC staging for individualized treatment.

Journal: Oral oncology
Published: July 16, 2025

ER stress upregulates S100A11 in steatohepatitis models via epigenetic modifications within the lipotoxicity-influenced enhancer.

ER stress upregulates S100A11 in steatohepatitis models via epigenetic modifications within the lipotoxicity-influenced enhancer.

Journal: The Journal of clinical investigation
Published: January 08, 2025

Silencing of S100A11 attenuates murine metabolic dysfunction-associated steatohepatitis.

Silencing of S100A11 attenuates murine metabolic dysfunction-associated steatohepatitis.

Journal: Npj gut and liver
Published: January 06, 2025

Deletion of sphingosine 1-phosphate receptor 1 in myeloid cells reduces hepatic inflammatory macrophages and attenuates MASH.

Deletion of sphingosine 1-phosphate receptor 1 in myeloid cells reduces hepatic inflammatory macrophages and attenuates MASH.

Journal: Hepatology communications
Published: June 21, 2024

Effects of apolipoprotein H downregulation on lipid metabolism, fatty liver disease, and gut microbiota dysbiosis.

Effects of apolipoprotein H downregulation on lipid metabolism, fatty liver disease, and gut microbiota dysbiosis.

Journal: Journal of lipid research
Published: October 03, 2023

MiR-205-5P AS POTENTIAL BIOMARKER AND THERAPEUTIC TARGET IN HEAD AND NECK SQUAMOUS CELL CARCINOMA.

MiR-205-5P AS POTENTIAL BIOMARKER AND THERAPEUTIC TARGET IN HEAD AND NECK SQUAMOUS CELL CARCINOMA.

Journal: Experimental oncology
Published: February 22, 2023

Macrophage RAGE activation is proinflammatory in NASH.

Macrophage RAGE activation is proinflammatory in NASH.

Journal: JCI insight
Published: January 25, 2023

MICRORNA-31 AS A POTENTIAL THERAPEUTIC BIOMARKER FOR ORAL SQUAMOUS CELL CARCINOMA: CURRENT EVIDENCE AND FUTURE PROSPECTS.

MICRORNA-31 AS A POTENTIAL THERAPEUTIC BIOMARKER FOR ORAL SQUAMOUS CELL CARCINOMA: CURRENT EVIDENCE AND FUTURE PROSPECTS.

Journal: Experimental oncology
Published: November 03, 2022

Foreseeing Alcohol-Associated Liver Disease through Proteomic Biomarkers.

Foreseeing Alcohol-Associated Liver Disease through Proteomic Biomarkers.

Journal: Clinical chemistry
Published: August 16, 2022

Liver-Derived S100A6 Propels β-Cell Dysfunction in NAFLD.

Liver-Derived S100A6 Propels β-Cell Dysfunction in NAFLD.

Journal: Diabetes
Published: January 19, 2022
Showing 1-12 of 18

Last Updated: 09/26/2026